Z79.81
Long term (current) use of agents affecting estrogen receptors and estrogen levels
Clinical Classification Guidelines
Use Additional Code
- code, if applicable, to identify:
- estrogen receptor positive status (Z17.0)
- family history of breast cancer (Z80.3)
- genetic susceptibility to malignant neoplasm (cancer) (Z15.0-)
- personal history of breast cancer (Z85.3)
- personal history of prostate cancer (Z85.46)
- postmenopausal status (Z78.0)
Excludes Type 1
- hormone replacement therapy (Z79.890)
Code First
- , if applicable:
- malignant neoplasm of breast (C50.-)
- malignant neoplasm of prostate (C61)
Medical Intelligence & Overview
ICD-10 code Z79.81 refers to the long-term or current use of medications that influence estrogen receptors and estrogen levels. These agents are often prescribed to manage hormone-related health conditions and require ongoing medical supervision. Understanding their purpose, potential effects, and considerations helps patients navigate their treatment plan effectively.
Causes & Symptoms
Clinical Causes: Hormone replacement therapy (HRT) for menopausal symptoms Treatment of hormone-sensitive cancers, such as breast cancer Management of certain gynecological conditions, like endometriosis Therapies aimed at regulating hormonal imbalances Preventative strategies for individuals at high risk of hormone-related disorders
Key Symptoms: Hot flashes and night sweats Changes in menstrual cycles Breast tenderness or swelling Mood swings or emotional changes Nausea or gastrointestinal discomfort Changes in weight or appetite Possible side effects related to specific medications, such as blood clots or bone density changes
Diagnostic & Treatment
Diagnosis Path: The diagnosis of long-term use of estrogen receptor and estrogen level affecting agents is primarily based on medical history and medication records. Healthcare providers may review prescriptions and monitor patient responses over time. Sometimes, blood tests are performed to assess hormone levels and evaluate treatment effects.
Treatment Protocols: Treatment involves carefully managed administration of medications that target estrogen receptors or modulate estrogen levels. Medical supervision ensures mitigation of side effects and effectiveness. Strategies may include:
Clinical Advice & FAQs
Billing Guidance
Is Z79.81 a billable ICD-10 code?
Yes, Z79.81 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report Z79.81?
Clinical documentation must specify the nature of Long term (current) use of agents affecting estrogen receptors and estrogen levels and any associated comorbidities for accurate reporting.
Cite this Clinical Reference